Cadenza Bio
Pre-clinicalCadenza Bio is a preclinical biotechnology company focused on developing a series of novel small-molecule drugs for the treatment of demyelinating and inflammatory diseases.
Founded
2020
Focus
Small Molecules
About
Cadenza Bio is a preclinical biotechnology company focused on developing a series of novel small-molecule drugs for the treatment of demyelinating and inflammatory diseases.
Funding History
1Total raised: $3.2M
Seed$3.2MUndisclosedSep 15, 2022
Company Info
TypePrivate
Founded2020
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile